


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31200045</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1615-5947</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of vascular surgery</Title>
                <ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Impact of Femoral Ossification on Local and Systemic Cardiovascular Patients' Condition.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0890-5096(19)30397-8</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2019.03.035</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Vascular calcifications are associated with a high cardiovascular morbi-mortality when located in the coronary territory, and with atheromatous plaque stability and stroke when located in carotid arteries. Previous studies have shown that femoral arteries were more prone to calcify and to develop osteoid metaplasia (OM). So far the impact of OM on local and systemic cardiovascular events remains unknown. The aim of this study was to assess the predictive value of OM in histological analysis of femoral plaque for the occurrence of mid- and long-term adverse cardiovascular events. Local inflammation has also been investigated.</AbstractText>
                <AbstractText Label="METHOD" NlmCategory="METHODS">Between 2008 and 2015, 86 femoral atheromatous samples were harvested during femoral endarterectomy (81 patients, 86 limbs) and processed for histomorphological analyses of calcifications and inflammation (monocytes/macrophages and B cells). Histological findings were compared with the long-term patients' follow-up, including major adverse cardiac event (MACE), major adverse limb event (MALE), mortality, Rutherford classification and ankle-brachial index (ABI). Frequencies were presented as percentage, continuous data as mean and standard deviation. A P-value &lt; .05 was considered statistically significant.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Median follow-up was 42.4 months [26.9 - 58.8]. Clinically, 23 (28%) patients underwent a MACE, and a MALE occurred in 18 (21%) limbs. The survival rate was 87.2% at 36 months. Histopathological analysis revealed osteoid metaplasia in 41 (51%) of the samples, without any significant impact on the occurrence of MACE, MALE or mortality. Sheet-like and nodule types seem to influence MACE but it was barely significant (.07 and .05, respectively), and a lack of nodule type was associated with MALE event (P=.01). The inflammatory analysis revealed among patients who presented a MACE, a significantly higher rate on pre-operative white blood cell formulae of monocytes (P=.04) and neutrophils (P=.04), correlated with higher B cells counts in plaque sample. Similarly, MALE were significantly associated with a higher rate of neutrophils in preoperative blood samples (P=.0008) and a higher number of B cells CD20+ in the samples.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Osteoid metaplasia is part of femoral calcifications in almost 50% of the cases but does not seem to be an independent predictive variable for MACE or MALE. However, a higher rate of B cells infiltration of the plaque and pre-operative neutrophils blood count may be predictive of adverse events during follow up, as well as nodule calcification's type.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Danvin</LastName>
                    <ForeName>Aurore</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>CHU Nantes, l'institut du thorax, service de chirurgie vasculaire, Nantes, F-44093.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Quillard</LastName>
                    <ForeName>Thibaut</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratoire de Physiopathologie de la Résorption Osseuse, Inserm UMR S 1238, Nantes, F-44000.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Espitia</LastName>
                    <ForeName>Olivier</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratoire de Physiopathologie de la Résorption Osseuse, Inserm UMR S 1238, Nantes, F-44000; CHU Nantes, unité de médicine vasculaire, Nantes, F-44093; Université de Nantes, Nantes, F-44000.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Charrier</LastName>
                    <ForeName>Céline</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratoire de Physiopathologie de la Résorption Osseuse, Inserm UMR S 1238, Nantes, F-44000.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guyomarch</LastName>
                    <ForeName>Béatrice</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>CHU Nantes, institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, F-44000.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gouëffic</LastName>
                    <ForeName>Yann</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>CHU Nantes, l'institut du thorax, service de chirurgie vasculaire, Nantes, F-44093; Laboratoire de Physiopathologie de la Résorption Osseuse, Inserm UMR S 1238, Nantes, F-44000; Université de Nantes, Nantes, F-44000.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maurel</LastName>
                    <ForeName>Blandine</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>CHU Nantes, l'institut du thorax, service de chirurgie vasculaire, Nantes, F-44093; Laboratoire de Physiopathologie de la Résorption Osseuse, Inserm UMR S 1238, Nantes, F-44000. Electronic address: blandine.maurel@chu-nantes.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Ann Vasc Surg</MedlineTA>
            <NlmUniqueID>8703941</NlmUniqueID>
            <ISSNLinking>0890-5096</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">MACE</Keyword>
            <Keyword MajorTopicYN="N">MALE –inflammation</Keyword>
            <Keyword MajorTopicYN="N">femoral calcifications</Keyword>
            <Keyword MajorTopicYN="N">osteoid metaplasia</Keyword>
            <Keyword MajorTopicYN="N">peripheral artery disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31200045</ArticleId>
            <ArticleId IdType="pii">S0890-5096(19)30397-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.avsg.2019.03.035</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

